Corporate Board Profile
Tech Score: 100/100
3 mention(s) identify CELESTE R. FRALICK, PH.D. as having software/technology expertise.
Company | Filing Date | Evidence | Reason |
---|---|---|---|
Aspira Women's Health Inc. | 2022-04-29 | Dr. Fralick recently retired as Chief Data Scientist at McAfee, a cybersecurity company... Prior to her position at McAfee, Dr. Fralick served as Principal Engineer and Chief Technology Officer at Intel. | Dr. Fralick was Chief Data Scientist at McAfee, a cybersecurity company, and held technical roles including Principal Engineer and CTO at Intel, indicating strong software-related technical skills. |
Aspira Women's Health Inc. | 2023-03-30 | Dr. Fralick retired in 2022 as Chief Data Scientist at McAfee, a cybersecurity company, which was spun-off from Intel Corporation in 2017. Prior to her position at McAfee, Dr. Fralick served as Principal Engineer and Chief Technology Officer at Intel. Since 2018, Dr. Fralick has served as Scientific Advisor to Innovatio, a privately held health predictive analytics company. She has also served as Managing Principal at Prukinje Science and Technology, LLC, a privately held data analytics consulting business, since 2019 and as a director for Prime Genomics, a privately held cancer diagnostic company, since 2020. Dr. Fralick earned a B.Sc. in Microbiology and Chemistry from Texas Tech University and a Ph.D. in Bioengineering from Arizona State University. | Has extensive executive-level leadership and management experience in technology and health sciences, including being Chief Data Scientist at McAfee, a cybersecurity company, and Principal Engineer and CTO at Intel. Holds a Ph.D. in Bioengineering. |
Aspira Women's Health Inc. | 2024-04-01 | Celeste R. Fralick, Ph.D. has served as Chief Technology & Data Officer, Technology Design of Choir Power since February 2023. Additionally, since 2018, Dr. Fralick has served as Chief Data Officer of Innovatio HealthDesign, a privately held health predictive analytics company. Previously, from 2017 to 2022, Dr. Fralick served as Chief Data Scientist at McAfee, a cybersecurity company, which was spun-off from Intel Corporation in 2017. Prior to her position at McAfee, Dr. Fralick served as Principal Engineer and Chief Technology Officer at Intel from 2015 to 2017. She has also served as Managing Principal at Prukinje Science and Technology, LLC, a privately held data analytics consulting business, from 2019 to 2022. Dr. Fralick earned a B.Sc. in Microbiology and Chemistry from Texas Tech University and a Ph.D. in Bioengineering from Arizona State University. | Has extensive executive-level leadership and management experience in technology and health sciences, including roles as Chief Data Scientist at a cybersecurity company and Chief Technology Officer at Intel, indicating strong software-related technical skills. |
Filing Date | Source Excerpt |
---|---|
2022-04-29 | Dr. Fralick recently retired as Chief Data Scientist at McAfee, a cybersecurity company... Prior to her position at McAfee, Dr. Fralick served as Principal Engineer and Chief Technology Officer at Intel. |
2023-03-30 | Dr. Fralick retired in 2022 as Chief Data Scientist at McAfee, a cybersecurity company, which was spun-off from Intel Corporation in 2017. Prior to her position at McAfee, Dr. Fralick served as Principal Engineer and Chief Technology Officer at Intel. Since 2018, Dr. Fralick has served as Scientific Advisor to Innovatio, a privately held health predictive analytics company. She has also served as Managing Principal at Prukinje Science and Technology, LLC, a privately held data analytics consulting business, since 2019 and as a director for Prime Genomics, a privately held cancer diagnostic company, since 2020. Dr. Fralick earned a B.Sc. in Microbiology and Chemistry from Texas Tech University and a Ph.D. in Bioengineering from Arizona State University. |
2024-04-01 | Celeste R. Fralick, Ph.D. has served as Chief Technology & Data Officer, Technology Design of Choir Power since February 2023. Additionally, since 2018, Dr. Fralick has served as Chief Data Officer of Innovatio HealthDesign, a privately held health predictive analytics company. Previously, from 2017 to 2022, Dr. Fralick served as Chief Data Scientist at McAfee, a cybersecurity company, which was spun-off from Intel Corporation in 2017. Prior to her position at McAfee, Dr. Fralick served as Principal Engineer and Chief Technology Officer at Intel from 2015 to 2017. She has also served as Managing Principal at Prukinje Science and Technology, LLC, a privately held data analytics consulting business, from 2019 to 2022. Dr. Fralick earned a B.Sc. in Microbiology and Chemistry from Texas Tech University and a Ph.D. in Bioengineering from Arizona State University. |
Data sourced from SEC filings. Last updated: 2025-10-11